Pathology, Clinical

• 

  Subject Areas on Research

  • A Twitter primer: Dos and don'ts for cytopathologists. 
  • American Gastroenterological Association Institute and College of American Pathologists Quality Measure Development for Detection of Mismatch Repair Deficiency and Lynch Syndrome Management. 
  • Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. 
  • Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. 
  • Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen. 
  • Comparison of fresh frozen serum to traditional proficiency testing material in a College of American Pathologists survey for ferritin, folate, and vitamin B12. 
  • Comparison of pooled fresh frozen serum to proficiency testing material in College of American Pathologists surveys: cortisol and immunoglobulin E. 
  • Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. 
  • Current Valuation of Pathology Service. 
  • Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Data Set for Reporting Carcinoma of the Stomach in Gastrectomy. 
  • Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR). 
  • Emerging From the Basement: The Visible Pathologist. 
  • Frontiers in Genitourinary Pathology. 
  • Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries. 
  • Immunohistochemistry in the diagnosis of cutaneous neoplasms. 
  • Impact of Uniform Methods on Interlaboratory Antibody Titration Variability: Antibody Titration and Uniform Methods. 
  • Informed consent for tissue research. 
  • Interobserver agreement on microfollicles in thyroid fine-needle aspirates. 
  • Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. 
  • Leukemia/lymphoma in cerebrospinal fluid: distinguishing between cases that performed well and poorly in the College of American Pathologists Interlaboratory Comparison Program in Non-gynecologic Cytology. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Measuring the significance of participant evaluation of acceptability of cases in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Microprobe analysis in human pathology. 
  • Pathologist Opinions about EPIC Beaker AP: a Multi-Institutional Survey of Early Adopters. 
  • Pathologists' slide storage: ice age technology comes to the rescue. 
  • Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a Critique. 
  • Pathology's Stepchild. 
  • Professional Practice Evaluation for Pathologists: The Development, Life, and Death of the Evalumetrics Program. 
  • Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. 
  • Q-Probes studies in anatomic pathology: quality improvement through targeted benchmarking. 
  • Randomized comparison of virtual microscopy and traditional glass microscopy in diagnostic accuracy among dermatology and pathology residents. 
  • Recommendations for the reporting of pleural mesothelioma. 
  • Reevaluation of the US Pathologist Workforce Size. 
  • Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring System. 
  • Simple and sensitive assay employing stable reagents for quantification of plasminogen activator. 
  • Social cytopathology: Building a stronger cytopathology community through social media. 
  • Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease. 
  • Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation. 
  • Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. 
  • The Pathologist Workforce in the United States: II. An Interactive Modeling Tool for Analyzing Future Qualitative and Quantitative Staffing Demands for Services. 
  • The Role of Machine Learning in Cardiovascular Pathology. 
  • The State of the Job Market for Pathologists: Evidence From the College of American Pathologists Practice Leader Survey. 
  • The clinical pathologist: physician, not administrator. 
  • The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice. 
  • The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. 
  • Total long-term within-laboratory precision of cortisol, ferritin, thyroxine, free thyroxine, and thyroid-stimulating hormone assays based on a College of American Pathologists fresh frozen serum study: do available methods meet medical needs for precision? 
  • Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia. 
  • Utility of additional tissue sections in dermatopathology: diagnostic, clinical and financial implications. 
  • Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ.